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Introduction: Obesity, which is excessive expansion of white adipose tissue, is a major risk factor for several serious
health issues, including diabetes, cardiovascular disease and cancer. Efforts to combat obesity and related diseases
require understanding the basic biology of adipogenesis. However, in vitro studies do not result in lipid
composition and morphology that are typically seen in vivo, likely because the in vitro conditions are not truly
representative of in vivo adipose tissue formation. In vitro, low oxygen tension and cytoskeletal tension have been
shown to independently regulate adipogenesis, but in vivo, these two factors simultaneously influence
differentiation.
Methods: The purpose of our study was to examine the influence of physiological oxygen tension on cytoskeletal
tension-mediated adipogenesis. Adipose-derived stem cells (ASCs) were differentiated under both ambient (20%)
and physiological (5%) oxygen conditions and treated with cytoskeletal inhibitors, cytochalasin D or blebbistatin.
Adipogenesis was assessed on the basis of gene expression and adipocyte metabolic function.
Results: Adipose tissue metabolic markers (glycerol-3-phosphate dehydrogenase (GPDH) and triglycerides) were
significantly down-regulated by physiological oxygen levels. Reducing cytoskeletal tension through the use of
chemical inhibitors, either cytochalasin D or blebbistatin, resulted in an up-regulation of adipogenic gene
expression (peroxisome proliferator-activated receptor γ (PPARγ), lipoprotein lipase (LPL) and fatty acid binding
protein 4 (FABP4)) and metabolic markers, regardless of oxygen levels. Cytochalasin D and blebbistatin treatment
altered cytoskeletal organization and associated tension via different mechanisms; however, both conditions had
similar effects on adipogenesis, suggesting that physiological oxygen-mediated regulation of adipogenesis in ASCs
is modulated, in part, by cytoskeletal tension.
Conclusions: These results demonstrated that interactions between the cytoskeleton and oxygen tension influence
adipogenic differentiation of ASCs.
Keywords: Adipogenesis, Cytoskeleton, Oxygen tension, Adipose-derived stem cellsIntroduction
Obesity is a critical health crisis facing our society. As of
2008, more than 39% of U.S. adults over the age of 20
were obese [1]. This population has a higher risk for
several diseases, including type 2 diabetes, cardiovascular
disease and various cancers [2], resulting in medical costs
of $147 billion annually [3]. Efforts to combat obesity and* Correspondence: CatherineK.Kuo@tufts.edu
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reproduction in any medium, provided the orrelated diseases require an understanding of the basic bio-
logy of adipogenesis. While gene knockout models have
revealed important insights into adipogenesis [4,5],
in vitro experiments have been useful for elucidating the
effects of individual factors, such as oxygen tension and
tissue stiffness on adipogenic differentiation [6,7]. What is
known about factors that regulate adipogenesis is based
largely on differentiation studies with preadipocyte cell
lines [8], mesenchymal stem cell lines [9] and primary mes-
enchymal stem cells (MSCs) [10]. Unfortunately, current
in vitro models used for studying white adipose tissueLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in vivo adipogenesis process, indicating that additional fac-
tors involved in differentiation still need to be addressed.
During adipogenesis in vitro, 3T3-F442A mouse
preadipocytes on tissue culture plastic undergo a morpho-
logical change, from fibroblastic to spherical, that appears
to be critical for differentiation [8]. In vivo, preadipocytes
appear spindle-shaped, while mature adipocytes grow in
size and develop an oval or rounded morphology as lipid
droplets accumulate intracellularly [11]. In vitro evidence
suggest that this shape change occurs early in the differenti-
ation process and prior to the up-regulation of many
adipocyte specific genes as well as independently of trigly-
ceride accumulation [12], though the cause andmechanism
for the morphological shift from fibroblastic to spherical
in vivo have yet to be determined. These morphological
changes are accompanied by cytoskeletal changes, includ-
ing decreased actin synthesis [8] and reorganization [13].
Altered actin organization may influence cytoskeletal
tension, which has been shown to regulate adipogenesis in
MSCs in vitro [14,15]. Though cytoskeletal changes appear
to be critical to the differentiation process, the detailed
mechanisms driving the morphological shift are not yet
understood.
Environmental cues, such as oxygen tension, also
factor into the regulation of adipogenic differentiation.
Adipogenesis in vitro is typically performed in ambient
air at 20% O2. In contrast, physiological O2 levels in
adult adipose tissue from lean human patients range
from 5.2 to 9.6%, while adipose tissue from obese human
patients is even lower with O2 levels in the range of 3.8
to 8.2% [16]. These ranges coincide with reports that
adipose tissue from lean mice has an average O2 level of
6.3%, while tissue from genetically modified obese mice
average 2.0% [17]. Interestingly, published in vitro stud-
ies on adipogenesis as a function of oxygen tension have
suggested that more physiologically relevant oxygen
levels can inhibit adipogenesis [6,18]. In contrast, others
have shown that low oxygen can induce an adipogenic
phenotype in telomerase-immortalized human MSCs,
though typical adipogenic gene markers were not up-
regulated, nor were the lipid morphology characteristic
of chemically induced adipocytes in vitro [19].
Cytoskeletal organization and oxygen tension have been
independently shown to regulate aspects of adipogenic dif-
ferentiation, but the combined effect has not yet been dem-
onstrated in human adipose-derived stem cells (ASCs).
ASCs are an ideal cell type for studying factors that may
regulate adipogenesis in vivo, as ASCs are found in adult
human adipose tissue [20-22], are capable of supporting
adipose tissue formation [23], and may participate in
adipogenesis of obese adipose tissue [24]. Additionally,
ASCs in vivo have long protrusions and a branched morph-
ology, not unlike preadipocytes, and in contrast to thespherical and large (diameters up to 100 μm)mature adipo-
cytes [24]. In this study, our objective was to examine how
cytoskeletal organization (and apparent tension) and oxy-
gen tension interact to regulate adipogenic differentiation
of ASCs in vitro. ASCs were adipogenically differentiated in
ambient air at 20% O2 or in a 5% O2 environment to more
closely replicate in vivo oxygen conditions. To alter cyto-
skeletal organization and apparent tension of the ASCs, we
exposed the cells to the chemical inhibitors cytochalasin D
and blebbistatin during the differentiation process. Cyto-
chalasin D reduces cytoskeletal tension by capping the
growing ends of f-actin filaments to prevent the addition of
monomers, thereby disrupting cytoskeletal organization
and reducing tension [25], whereas blebbistatin alters the
actin cytoskeleton by inhibiting rigid non-muscle myosin
type II crosslinking with actin [26]. To assess the effects of
oxygen tension and cytoskeletal inhibition on adipogenesis,
we analyzed both early and late markers of adipogenic dif-
ferentiation, specifically peroxisome proliferator-activated
receptor γ (PPARγ), lipoprotein lipase (LPL) and fatty acid
binding protein 4 (FABP4) gene expression, as well as




Tissue culture reagents, including Dulbecco’s Modified
Eagle Medium (DMEM), fetal bovine serum (FBS), human
insulin and penicillin/streptomycin, were purchased from
Invitrogen (Carlsbad, CA, USA). Unless otherwise noted,
all other chemicals were purchased from Sigma-Aldrich
(St. Louis, MO, USA).
Cell culture
Primary human ASCs used in this study were isolated
from subcutaneous adipose tissue samples harvested from
the abdomen of three healthy adult female donors (body
mass index (BMI) range: 21 to 27; age range: 40 to 59).
ASCs were obtained from existing stores and were de-
identified and, therefore, were not considered human
research subjects and did not require ethics approval; do-
nors provided written informed consent for the collection
of the adipose tissue. ASCs were plated at 20,000 cells/
cm2 in growth medium (DMEM, 10% FBS, and 100 U/mL
penicillin and 100 μg/mL streptomycin) and allowed to
grow to confluence. Two days post-confluence, growth
medium was replaced with adipogenic induction me-
dium containing DMEM, 3% FBS, 33 μM biotin, 17 μM
pantothenate, 1 μM insulin, 1 μM dexamethasone,
400 μM 3-isobutyl-1-methylxanthine (IBMX), 5 μM
2,3-thiazolidinedione (TZD), 100 U/mL penicillin and
100 μg/mL streptomycin as previously reported [27].
After one week, the adipogenic induction medium
was replaced with maintenance medium consisting of
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were cultured under ambient (20%) or physiological
(5%) O2 conditions at 37°C in humidified incubators
using nitrogen gas to control O2 levels. Medium changes
were performed every other day for 21 days.
Cytoskeletal inhibition
To inhibit cytoskeletal tension, cells were treated with
either 2 μM cytochalasin D in dimethyl sulfoxide (DMSO)
or 50 μM blebbistatin in DMSO at each medium change.
The final concentration of DMSO in the medium was 1%
v/v and, therefore, 1% DMSO was used in the culture
medium as a vehicle control. Concentrations were based
on previously published studies [14,15].
Triglyceride content
One of the hallmarks of adipogenesis is the formation of
microscopic lipid vacuoles storing triglycerides. Meta-
bolic analysis of triglyceride content was conducted on
the cell lysates as previously described [28]. After 14
and 21 days, cells were trypsinized with 0.05% trypsin-
ethylenediaminetetraacetic acid (EDTA) and pelleted by
centrifuging at 1,000 × g for 10 minutes at 4°C. Cell pel-
lets were washed with phosphate buffered saline (PBS)
and re-pelleted. Afterwards, the pellets were dissolved
in 50 μL of STES buffer (2 nM NaCl, 50 nM Tris, 10
nM EDTA, 0.001% w/v sodium dodecyl sulfate) and fro-
zen at -20°C until analysis. Previously frozen cells were
thawed and sonicated using 60% amplification for one
second. Samples were centrifuged at 20,000 × g for 10
minutes at 4°C to remove the cellular debris. The super-
natant was collected and transferred into a new micro-
centrifuge tube. Triglyceride content of the supernatant
was measured using a triglyceride determination kit,
which analyzed the release of glycerol from triglycerides
by lipoprotein lipase. Triglyceride values were normal-
ized to total DNA content using Hoechst 33258 dye
(Invitrogen).
Glycerol-3-phosphate dehydrogenase (GPDH; EC 1.1.1.8)
enzyme activity
GPDH is a cytoplasmic enzyme involved in the triglycer-
ide biosynthesis pathway converting dihydroxyacetone
phosphate into glycerol 3-phosphate [12]. GPDH activity
increases during terminal adipogenic differentiation and
adipocyte maturation [29]. At days 14 and 21 following
adipogenic induction, GPDH activities were measured in
situ using the method of Sottile and Seuwen [30]. Briefly,
cell lysate samples were incubated at 37°C in a solution
consisting of 0.1 M triethanolamine, 2.5 mM EDTA,
0.1 mM β-mercaptoethanol, 334 μM nicotinamide aden-
ine dinucleotide (NADH), pH adjusted to 7.7 with 1 M
HCl. To start the reaction, dihydroxyacetone phosphate
was added to the mix at a final concentration of 0.2 mM.GPDH activity was assessed by measuring the NADH
absorbance at 340 nm using a microplate reader
(VERSAmax, Molecular Devices, LLC, Sunnyvale, CA,
USA). Initial and final absorbance values were recorded
after 15 minutes. These values were converted to NADH
concentration, which were then used to determine GPDH
activity. GPDH activity was normalized to total DNA con-
tent determined using Hoechst dye.
Total DNA content
DNA content of the samples was conducted by staining
an aliquot of the cell lysates with Hoechst dye. Fluores-
cence values for these samples were acquired on a fluor-
escence microplate reader (SpectraMax Gemini EM,
Molecular Devices, LLC, Sunnyvale, CA, USA) using an
excitation wavelength of 360 nm and an emission wave-
length of 460 nm. These values were then converted to
total DNA content by comparing the fluorescence values
to a standard curve of fluorescence readings generated
from solutions with known DNA concentrations.
Histology
Samples were rinsed with PBS, fixed for 20 minutes in
4% paraformaldehyde, and washed again with PBS. After
fixation, samples were blocked with 3% bovine serum al-
bumin and then stained with Alexa Fluor 488 conjugated
phalloidin (Invitrogen) to visualize actin microfilaments.
Nuclei were counterstained with Hoechst dye. Images of
the phalloidin-stained cells were captured using a Leica
DM IL fluorescence microscope (Leica Microsystems,
Buffalo Grove, IL, USA) with an excitation wavelength of
495 nm and an emission wavelength of 518 nm. Hoechst
images were captured using an excitation wavelength of
350 nm and an emission wavelength of 460 nm.
Oil Red O staining
Lipid vacuoles were visualized with Oil Red O staining.
On days 14 and 21 post-induction, the cells were fixed
for 20 minutes using a 4% paraformaldehyde solution.
Lipids were stained with a 0.21% (w/v) Oil Red O in 60%
(v/v) isopropanol-PBS solution. Samples were then thor-
oughly washed with PBS over the course of several hours
to remove any unbound dye. Images were captured
using a Leica DM IL fluorescence microscope using an
excitation wavelength of 560 nm and an emission wave-
length of 645 nm.
Quantitative Polymerase Chain Reaction (qPCR)
Each cell sample was homogenized in TRIzol reagent
(Invitrogen) and total RNA was extracted according to the
manufacturer’s protocol. RNA concentration and quality
were assessed spectrophotometrically on the basis of the
A260/A280 readings. Reverse transcription was performed
using Superscript III First-Strand Synthesis System
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oligo(dT) primers. qPCR was performed with Brilliant II
SYBR Green qPCR Master Mix (Applied Biosystems,
Foster City, CA, USA) and the MX3000p qPCR System
(Agilent Technologies, Santa Clara, CA, USA). Primer
pairs were designed and optimized for qPCR analysis of
expression levels of 18S rRNA (forward 5′-gactcaacacggg
aaacctcacc-3′; reverse 5′-accagacaaatcgctccaccaact-3′),
PPARγ (forward 5′-aatgccatcaggtttgggcgga-3′; reverse 5′-
cgccctcgcctttgctttgg-3′), LPL (forward 5′-gctcgtgctgactctggcc
g-3′; reverse 5′-tcttctttggtcggcggcgg-3′), and FABP4 (for-
ward 5′-tgataaactggtggtggaatgcgtc-3′; reverse 5′- ctctctcat
aaactctcgtggaagtg-3′). Expression levels relative to 18S
rRNA were calculated using the delta-delta cycle thresh-
old method.
Statistical analysis
All experiments were performed in triplicate with cells
from three donors. Comparisons of treatment group
means as a function of oxygen tension or time were
performed using unpaired Student’s t-tests. Comparisons
of treatment group means as a function of cytoskeletal
tension inhibitor were conducted using one-way ANOVA
with Tukey’s post-hoc test. Treatment group means were
deemed to be statistically significant when P <0.05.
Results
Cytoskeletal organization
Control ASCs showed spread actin microfilament forma-
tion (Figure 1A). Cells treated with cytochalasin D deve-
loped a shrunken morphology as the result of actin
microfilament degradation, evident by the presence of
altered and shorter actin microfilaments as compared
to the control group (Figure 1B). ASCs treated with
blebbistatin were incapable of maintaining a spread cell
morphology, presumably because crosslinking between
non-muscle myosin II and actin filaments was inhibited.
Phalloidin-stained images showed that the actin microfil-
aments in cells of the blebbistatin group were shorter
and the network was disrupted as compared to the con-
trol group (Figure 1C).Figure 1 Cytoskeletal morphology as a function of inhibitor treatmen
actin microfilament structure of non-inhibited adipose-derived stem cells (A
cytochalasin D (B) and 50 μM blebbistatin (C). ASC nuclei were counterstai
and blebbistatin inhibited non-muscle myosin type II activity, altering cell mProliferation
Total DNA content at different time points was assessed
to examine whether reduced oxygen level or altered cyto-
skeletal organization compromised viability or affected
proliferation (Figure 2). DNA content did not significantly
change (P >0.05) as a function of oxygen tension, cytoskel-
etal inhibition, or time over the course of the 21-day dif-
ferentiation period.
Adipogenic gene expression
The effects of oxygen tension and cytoskeletal inhibitors
on adipogenesis were assessed based on gene expression
levels for PPARγ, LPL and FABP4 (Figure 3). In the ab-
sence of a cytoskeletal inhibitor, LPL expression of cells
under 5% O2 decreased slightly at Day 7 as compared to
control cells under 20% O2, but was not significantly dif-
ferent (P >0.05). At Day 7 under 5% O2, there was a nu-
merical increase in PPARγ and FABP4 expression levels,
but these trends were inconsistent across the three donors
and were not statistically significant. At Day 21, FABP4
expression decreased significantly (18.5-fold less; P <0.05)
under 5% O2 as compared to 20% O2 (Figure 3F). Expres-
sion of PPARγ and LPL also decreased (1.5- and 1.3-fold
less, respectively), but these differences were not signifi-
cant. From Day 7 to Day 21, PPARγ and FABP4 gene
expression levels slightly increased under 20% O2 (1.5-
and 3.7-fold; P >0.05), but PPARγ and FABP4 significantly
decreased under 5% O2 (2.2- and 6.5-fold; P <0.05;
Figure 3). LPL increased under 20% O2 (2.5-fold) and 5%
O2 (2.1-fold) from days 7 to 21; however, neither up-
regulation was significant (P >0.05).
Under 20% O2, the addition of cytochalasin D and
blebbistatin to the differentiation medium significantly
increased the expression levels of all three adipogenic
markers at Day 7, as compared to non-inhibited controls
(P <0.05; Figure 3). Cytochalasin D and blebbistatin sig-
nificantly increased the expression of PPARγ by 5.5- and
3.4-fold (Figure 3A), LPL by 8.0- and 9.1-fold (Figure 3C),
and FABP4 by 22.5- and 14.3-fold (Figure 3E), respec-
tively, as compared to non-inhibited controls (P <0.05).
At 21 days, cytochalasin D and blebbistatin treatmentt. Alexa Fluor 488 conjugated phalloidin (green) staining showed the
SCs) (A), and the disrupted cytoskeleton of ASCs cultured with 2 μM
ned with Hoechst (blue). Cytochalasin D inhibited actin polymerization
orphology. Scale bar = 30 μm.
Figure 2 Proliferation as a function of oxygen levels and cytoskeletal inhibition. To assess proliferation, DNA content (μg/well) was
analyzed after 0, 14 and 21 days of differentiation. Adipose-derived stem cells (ASCs) were exposed to 20% O2 and 5% O2 conditions, and treated
with cytochalasin D (checkered), blebbistatin (striped) or vehicle control (solid). Oxygen levels and cytoskeletal conditions did not significantly
change DNA content over 21 days.
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17.7-fold (Figure 3B), LPL expression by 9.7-fold (cytocha-
lasin D only; Figure 3D) and FABP4 expression by 253.8-
and 30.2-fold (Figure 3F), respectively, as compared to
non-inhibited controls (P <0.05).
Combining inhibitor treatment under reduced oxygen
tension led to similar increases in PPARγ, LPL and FABP4
expression levels at Day 7 as compared to inhibitorFigure 3 Adipogenic gene expression as a function of oxygen levels a
cultured under 20% O2 (white) and 5% O2 (black) conditions, and treated w
(control). All transcript levels were normalized to 18 S ribosomal RNA, and
proliferator-activated receptor γ (PPARγ) (A, B), lipoprotein lipase (LPL) (C, D
analyzed on days 7 and 21. Culturing under 5% O2 conditions significantly
20% O2 control group at Day 21. Cytoskeletal inhibitors significantly increas
point as compared to non-inhibited controls. Cytoskeletal inhibitors applied
and FABP4 (E) gene expression as compared to the corresponding 20% O2
n = 3 donors; * = significant change relative to non-inhibited control unde
relative to corresponding 20% O2 sample with P <0.05; • = significant chan
was only reported for trends that were consistent for all three cell donors.treatment under ambient oxygen tension (Figure 3). How-
ever, the combined effects were substantially greater in
magnitude. Under 5% O2, treatment with cytochalasin D
and blebbistatin significantly increased the expression
levels of PPARγ by 8.0- and 5.3-fold (Figure 3A), LPL by
23.0- and 13.7-fold (Figure 3C), and FABP4 by 54.5- and
35.0-fold (Figure 3E), respectively, as compared to the
corresponding control cells under the same oxygennd cytoskeletal inhibition. Adipose-derived stem cells (ASCs) were
ith cytochalasin D (cyto), blebbistatin (bleb) or vehicle control
then to 20% O2, non-inhibited (control) samples on Day 7. Peroxisome
) and fatty acid binding protein 4 (FABP4) (E, F) expression were
decreased FABP4 in the non-inhibited control group compared to the
ed adipogenic gene expression regardless of oxygen levels or time
under 5% O2 conditions led to a significant increase in PPARγ (A)
inhibited samples at Day 7. Values are reported as mean ± SEM of
r the same oxygen condition with P <0.05; † = significant change
ge relative to corresponding Day 7 sample with P <0.05. Significance
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O2 with cytochalasin D and blebbistatin treatment did not
change significantly from Day 7 to Day 21 (P >0.05).
Blebbistatin treatment at 21 days under 5% O2 resulted in
a significant decrease in LPL expression, but no change
was seen with cytochalasin D treatment, compared to the
corresponding 5% O2, Day 7 sample. Expression of FABP4
under 5% O2 also remained constant in blebbistatin-
treated cells from Day 7 to Day 21, but increased in cyto-
chalasin D treated cells, though not significantly. Similar
to ambient oxygen tension, inhibitor treatment led to sig-
nificant increases in all gene expression levels under re-
duced oxygen tension at Day 21 as compared to non-
inhibited control groups with the exception of LPL ex-
pression in the blebbistatin treated group. Under 5% O2,
treatment with cytochalasin D and blebbistatin signifi-
cantly increased the expression levels of PPARγ by 27.9-
and 15.3-fold (Figure 3B), LPL by 10.5-fold (cytochalasin
D only; Figure 3D), and FABP4 by 614.0- and 227.0-fold
(Figure 3F), respectively, as compared to the control cells
under reduced oxygen tension at Day 21 (P <0.05).
Lipid metabolism
As a functional measure of the effect of the oxygen tension
and cytoskeletal tension on adipogenic differentiation, we
analyzed lipid metabolism by assessing lipid droplet forma-
tion, cytoplasmic GPDH activity and triglyceride content.
Regardless of oxygen tension or cytoskeletal inhibitor treat-
ment, all experimental groups showed microscopic lipid
droplets after 21 days following adipogenic induction as in-
dicated by Oil Red O staining (Figure 4). In control cells
without inhibitor treatment, reducing the oxygen tension
to 5% O2 lowered both GPDH activity (Figure 5) andFigure 4 Lipid morphology as a function of oxygen levels and cytosk
changes in lipid accumulation in adipose-derived stem cells (ASCs) that ha
ASCs under 20% O2 conditions without cytoskeleton inhibitor treatment (A
compared to ASCs under 5% O2 conditions without inhibitor treatment (D
blebbistatin (C,F), appeared to increase the percentage of lipid stained cell
(A,D). ASC nuclei were counterstained with Hoechst (blue). Scale bar = 30triglyceride accumulation (Figure 6). At 14 days, triglycer-
ide content was significantly reduced by 1.3-fold (P <0.05)
with 5% O2 (Figure 6A). At 21 days, GPDH activity
(Figure 5B) and triglyceride content (Figure 6B) were
significantly reduced by 2.8- and 1.9-fold, respectively
(P <0.05). Adding the cytoskeletal inhibitors increased
GPDH activity and triglyceride accumulation under both
ambient and reduced oxygen tensions, compared to non-
inhibited controls. The up-regulation in GPDH activity
under reduced oxygen tension was more pronounced after
21 days, when the effects of both cytochalasin D and
blebbistatin were significant (P <0.05; Figure 5B). Similar
trends with cytochalasin D and blebbistatin treatment were
observed for triglyceride accumulation, although triglycer-
ide content at 21 days was only slightly larger than at 14
days (Figure 6). After 21 days under 5% O2, cytochalasin D
and blebbistatin treatment increased GPDH activity of cells
(17.5 and 19.3mU/μg-DNA, respectively) to GPDH activity
levels that were similar to non-inhibited control cells under
20% O2 (17.7 mU/μg-DNA) (Figure 5B). Under 5% O2, cy-
tochalasin D and blebbistatin treatment elevated triglycer-
ide content compared to non-inhibited control cells under
20% after both 14 and 21 days (Figure 6).
Discussion
To better understand the role of mechanical and environ-
mental factors in adipogenesis, we have examined how
altered cell morphology (and the associated decrease
in cytoskeletal tension) may synergistically interact with
physiological oxygen conditions to regulate adipogenic dif-
ferentiation of ASCs. In this study, we demonstrated a
significant influence of cytoskeletal organization on
adipogenic differentiation under both physiological andeletal inhibition. Oil Red O staining (red) qualitatively demonstrated
d been differentiated for 21 days in 20% O2 and 5% O2 conditions.
) appeared to have a higher percentage of Oil Red O positive cells
). The addition of either cytoskeletal inhibitor, cytochalasin D (B,E) or
s regardless of oxygen conditions compared to non-inhibited ASCs
μm.
Figure 5 Glycerol-3-phosphate dehydrogenase (GPDH) activity
as a function of oxygen levels and cytoskeletal inhibition. GPDH
activity was analyzed after 14 and 21 days of differentiation.
Adipose-derived stem cells (ASCs) were cultured under 20% O2
(white) and 5% O2 (black) conditions, and treated with cytochalasin
D (cyto), blebbistatin (bleb) or vehicle control (control). In control
groups, 5% O2, reduced GPDH activity after 14 (A) and significantly
at 21 (B) days, compared to 20% O2. Conversely, cytochalasin D and
blebbistatin increased GPDH activity compared to non-inhibited
samples, regardless of oxygen condition after 14 (A) and 21 (B) days.
Values were reported as mean ± SEM with n = 3 cell donors; * =
significant change relative to non-inhibited control under the same
oxygen condition with P <0.05; † = significant change relative to
corresponding 20% O2 sample with P <0.05. Significance was only
reported for trends that were consistent for all three cell donors.
Figure 6 Triglyceride content as a function of oxygen levels
and cytoskeletal inhibition. Triglyceride content was analyzed after
14 and 21 days of differentiation. Adipose-derived stem cells (ASCs)
were cultured under 20% O2 (white) and 5% O2 (black) conditions,
and treated with cytochalasin D (cyto), blebbistatin (bleb) or vehicle
control (control). In control groups, 5% O2 significantly reduced
triglyceride content compared to 20% O2 after 14 (A) and 21
(B) days. Conversely, cytochalasin D and blebbistatin increased
triglyceride content compared to non-inhibited samples, regardless
of oxygen condition after 14 (A) and 21 (B) days. Values were
reported as mean ± SEM with n = 3 cell donors; * = significant
change relative to non-inhibited control under the same oxygen
condition with P <0.05; † = significant change relative to
corresponding 20% O2 sample with P <0.05. Significance was only
reported for trends that were consistent for all three cell donors.
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inhibitors to reduce apparent cytoskeletal tension in pri-
mary adult human ASCs enhanced the expression of
adipogenic marker genes as well as functional indicators
of lipid metabolism.
Combining physiological oxygen and cytoskeletal in-
hibition had a dramatic impact on ASC adipogenesis.
Under physiological oxygen tension with cytoskeletal in-
hibition, PPARγ and FABP4 gene expression levels were
significantly increased following seven days of induction
compared to ambient oxygen and non-inhibited controls
(Figure 3). These trends were maintained following 21
days of induction. Exposure to physiological oxygen
tension for 21 days significantly down-regulated FABP4
gene expression, but cytoskeletal inhibition reversed this
decrease (Figure 3). Physiological oxygen tension also
significantly decreased GPDH activity (Figure 5) and
triglyceride accumulation (Figure 6). These decreases in
functional markers of mature adipocytes may be related
to the diminished FABP4 gene expression.
Based on our results, we postulate that within the
in vivo ASC niche at physiological oxygen levels, cytoske-
letal tension may regulate adipose tissue expansion. Thecombined effect of cytoskeletal tension and physiological
oxygen levels on ASCs has not been previously reported.
Our observations on the effects of either cytoskeletal in-
hibition or reduced oxygen tension, applied individually,
are qualitatively consistent with previously published stud-
ies using other types of stem cells. Reducing cytoskeletal
tension via cytochalasin D and blebbistatin induced roun-
ded cell morphology and up-regulated adipogenesis in
MSCs [14] and C3H10T1/2 cells, an immortalized MSC
line [15]. In vivo and in vitro, preadipocytes possess a
fibroblastic morphology; however, mature adipocytes are
more spherical [8,11]. The mechanisms driving the
morphological change during adipogenesis in vivo remain
unclear. In the present study, we chose to induce these
changes in vitro through the use of chemical inhibitors
that target intracellular cytoskeletal tension. While cyto-
chalasin D and blebbistatin act through different mecha-
nisms to disrupt the actin cytoskeleton, they produced
similar cell shape changes and enhanced adipogenesis,
suggesting that the enhancement is due to actin disassem-
bly and reorganization.
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lower than the ambient oxygen tension typically used in
cell culture studies, has been shown to inhibit stem cell
differentiation and aid in maintaining pluripotency
through hypoxia-inducible factor (HIF)-regulated path-
ways [31]. Previous in vitro adipogenesis studies using
low oxygen conditions or chemical treatments mimick-
ing hypoxia have demonstrated that low oxygen ten-
sion inhibits or reduces adipogenic differentiation in
preadipocyte cell lines [6,17,18]. Studies with primary
stem cells found that low oxygen conditions not only re-
duced lineage commitment in ASCs [32], but extended
the differentiation potential in adipose tissue stromal
cells [33] and bone marrow-derived MSCs [34] com-
pared to ambient oxygen conditions. Additionally, when
cultured under low oxygen, human MSCs showed di-
minished adipogenic differentiation and FABP4 gene ex-
pression [35]. Similar to the MSCs, we demonstrated
suppression of adipogenic differentiation marker expres-
sion (FABP4, GPDH and triglycerides) in the ASCs
under physiological oxygen conditions. In contrast,
ASCs cultured under chondrogenic conditions and 5%
O2 significantly increased cartilaginous matrix produc-
tion while cell proliferation decreased [22]. Taken to-
gether, these and our findings demonstrate that reducing
the oxygen tension to a physiological level can differen-
tially regulate the switch between growth and differenti-
ation in ASCs.
The FABP4 gene encodes an intracellular fatty acid
binding protein that is found in differentiated adipo-
cytes [36]. During adipogenesis, the adipogenic tran-
scription factors PPARγ and CCAAT/enhancer
binding protein α (C/EBPα) induce FABP4 mRNA ex-
pression, resulting in increased FABP4 protein synthe-
sis [37]. Studies with FABP4-deficient mice revealed
that FABP4 plays a role in adipocyte fatty acid metab-
olism, triglyceride storage and insulin resistance [38].
Our results showed that low oxygen tension reduced
FABP4 gene expression relative to ambient oxygen tension
in ASCs at 21 days (Figure 3). This was consistent with an
earlier study involving MSCs [35], though the exact mech-
anism for FABP4 reduction was not examined. We did not
find a corresponding decrease in PPARγ, which typically
regulates FABP4 expression, suggesting that FABP4 expres-
sion may also be controlled through a different mechanism.
The ASCs with reduced FABP4 expression also had signifi-
cantly decreased triglyceride content and GPDH activity,
suggesting that lipid synthesis and storage can also respond
to lowered oxygen tension via a PPARγ-independent
mechanism. Interestingly, cytoskeletal inhibition abolished
the physiological oxygen-mediated down-regulation of
adipogenic markers, suggesting that cytoskeletal tension
may act as an overriding regulator of ASC-to-adipocyte dif-
ferentiation in vivo.Our results indicate there may be significant crosstalk
between the oxygen tension and cytoskeletal pathways
to regulate adipogenesis, though specific signaling path-
ways have yet to be elucidated. Unfortunately, current
literature does not provide a clear picture of how oxygen
tension and cytoskeletal tension pathways interact. Sev-
eral pathways regulate adipogenesis via cytoskeletal ten-
sion, including the RhoA/Rho-associated protein kinase
(ROCK) pathway. ROCK is capable of phosphorylating
several molecules, including myosin light chain and
myosin light chain phosphatase. The phosphorylation of
these molecules increases non-muscle myosin type II ac-
tivity, which regulates the tension between actin micro-
filaments. Several studies have shown that RhoA/ROCK-
mediated cytoskeletal tension can be a key regulator of
adipogenesis in stem cells [14,15]. Treatment of the
cells with cytochalasin D or blebbistatin led to an up-
regulation of adipogenic gene expression (Figure 3) and
an increase in GPDH activity (Figure 5) and triglyceride
content (Figure 6) suggesting that the RhoA/ROCK
pathway could be involved. However, the previous studies
on cytoskeletal tension and adipogenesis were conducted
under ambient oxygen conditions and did not address the
effects that low oxygen tension would have on the differ-
entiation process. The few studies that did examine how
the RhoA/ROCK pathway functions under low oxygen
suggest that RhoA activation induces HIF-1α expression
[39]. HIF-1α is regarded as the primary transcription fac-
tor of hypoxia-regulated functions and has been linked to
the down-regulation of adipogenesis in vitro by inhibiting
the transcription of C/EBPβ and PPARγ in 3T3-L1
preadipocytes [6,18]. However, the studies linking HIF-1α
and RhoA did not indicate whether downstream compo-
nents of the RhoA/ROCK pathway, specifically, cytoskel-
etal tension, were involved in regulating HIF-1α [39].
A potential limitation of this study is the use of small
molecule chemical inhibitors to disassemble the actin
microfilaments (via cytochalasin D) or to inhibit non-
muscle myosin type II binding to actin (via blebbistatin)
to reduce cytoskeletal tension and alter cell shape. These
inhibitors affect the cell morphology leading to cell
rounding, whereas cellular shape may also be regulated
by extracellular matrix factors, such as substrate stiff-
ness. Exploring external mechanical factors with an in-
tact actin cytoskeleton may provide additional insights
into how cell shape influences and is controlled during
adipogenesis in vivo. ASCs and mature adipocytes occupy
unique extracellular niches within the adipose tissue envir-
onment [24], and differences between niche mechanical
properties could have a significant impact on actin cyto-
skeleton assembly, morphology and mechanotransduction.
For instance, ASCs cultured on a soft substrate demon-
strated an amorphous actin cytoskeleton and rounded
morphology, compared to the pronounced actin filaments
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strates [40]. Our current study lays the foundation for
investigating synergetic effects of the cytoskeleton and
oxygen tension. Future studies will focus on regulating the
actin cytoskeleton through other means such as matrix
stiffness, which has previously been shown to influence
adipogenesis [7]. A second potential limitation of this
study and nearly all in vitro adipogenic differentiation
studies is the use of synthetic chemical cocktails to induce
differentiation. This methodology is well established to
study stem cell biology, but is likely not entirely represen-
tative of in vivo differentiation conditions. Therefore, we
must use caution when extrapolating in vitro results to
in vivo differentiation. Additionally, this study was con-
ducted in a typical two-dimensional monolayer culture,
making the results easier to compare with prior studies.
Future studies are warranted to conduct experiments in
three-dimensional culture systems that more closely
mimic the in vivo microenvironment.
Conclusion
In summary, we have found that altering cytoskeletal
organization and associated tension in ASCs enhances
adipogenic differentiation. Physiological oxygen levels
depressed adipogenic differentiation markers, but this
down-regulation was abolished with cytoskeletal inhib-
ition. This study demonstrates the profound and perhaps
overriding influence that the cytoskeleton has in regulat-
ing the fate decisions of ASCs. Further studies are still
needed to elucidate the molecular pathways. The out-
comes of these studies could have implications in several
areas, including obesity research as well as developing
in vitro adipose tissue models.
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